Vericel VCEL
NASDAQ VCEL
$59.45 +0.42 (+0.71%)
At close: Nov 11, 2026 · 4:00 PM EST

Vericel (VCEL) Net Short-Term Debt Issued (Repaid) (2017 - 2018)

Updated

Analysis

Vericel (VCEL) Net Short-Term Debt Issued (Repaid) (2017 - 2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net ST Debt (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -5.28 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.28 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -499.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -682.00 Mn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -87.00 Mn
10 Vericel 3.01 Bn 2.40 Bn 62.61 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2018 -10,000.00
Dec 31, 2017 -889,000.00
API Access

Vericel Net Short-Term Debt Issued (Repaid) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=VCEL&period=max&api_key=YOUR_API_KEY